Improving access to cancer clinical trials for racial and ethnic minorities
Advancing Clinical Trials: Working through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDERS)
This study is working to help more people from different racial and ethnic backgrounds join cancer clinical trials, so they can access the latest treatments and make sure that research includes everyone.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | H. Lee Moffitt Cancer Ctr & Res Inst NIH-funded |
| Lab location | 1 site (Tampa, United States) |
| Project ID | NIH-10914780 on NIH RePORTER |
What this research studies
This research aims to enhance the participation of racial and ethnic minorities in cancer clinical trials, addressing the disparities in cancer care. It employs a multi-faceted approach that includes community outreach, navigation support, and digital referral strategies to connect patients with clinical trial opportunities. By working closely with community health educators and leveraging digital tools, the project seeks to overcome barriers such as knowledge gaps, trust issues, and logistical challenges that prevent minority patients from enrolling in trials. The goal is to ensure that these patients have access to cutting-edge cancer treatments and that clinical trial findings are more representative of diverse populations.
Who could benefit from this research
Good fit: Ideal candidates for this research are racial and ethnic minority patients diagnosed with cancer who are seeking treatment options.
Not a fit: Patients who are not part of racial or ethnic minority groups may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve access to innovative cancer treatments for racial and ethnic minority patients.
How similar studies have performed: Previous research has shown that community engagement and digital strategies can effectively increase minority participation in clinical trials, indicating a promising approach.
Where this research is happening
Tampa, United States
- H. Lee Moffitt Cancer Ctr & Res Inst — Tampa, United States (Active)
Researchers
- Principal investigator: Vadaparampil, Susan T — H. Lee Moffitt Cancer Ctr & Res Inst
- Study coordinator: Vadaparampil, Susan T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.